Characterization of Impurities and Degradants Using Mass Spectrometry
Latest Publications

TOTAL DOCUMENTS

(FIVE YEARS 0)

H-INDEX

(FIVE YEARS 0)

Published By John Wiley & Sons, Inc.

9780470921371, 9780470386187

Latest Documents Most Cited Documents Contributed Authors Related Sources Related Keywords

Isotope Patten Recognition on Molecular Formula Determination for Structural Identification of Impurities

Characterization of Impurities and Degradants Using Mass Spectrometry ◽

10.1002/9780470921371.ch6 ◽

2011 ◽

pp. 183-211

Author(s):

Ming Gu

Keyword(s):

Structural Identification ◽

Molecular Formula ◽

Molecular Formula Determination

Download Full-text

Frontmatter

Characterization of Impurities and Degradants Using Mass Spectrometry ◽

10.1002/9780470921371.fmatter ◽

2011 ◽

pp. i-xxii

Download Full-text

Impurity Identification for Drug Substances

Characterization of Impurities and Degradants Using Mass Spectrometry ◽

10.1002/9780470921371.ch8 ◽

2011 ◽

pp. 231-250

Author(s):

David W. Berberich ◽

Tao Jiang ◽

Joseph McClurg ◽

Frank Moser ◽

R. Randy Wilhelm

Keyword(s):

Drug Substances

Download Full-text

Orbitrap High-Resolution Applications

Characterization of Impurities and Degradants Using Mass Spectrometry ◽

10.1002/9780470921371.ch4 ◽

2011 ◽

pp. 109-134

Author(s):

Robert J. Strife

Keyword(s):

High Resolution

Download Full-text

Structure Elucidation of Pharmaceutical Impurities and Degradants in Drug Formulation Development

Characterization of Impurities and Degradants Using Mass Spectrometry ◽

10.1002/9780470921371.ch10 ◽

2011 ◽

pp. 279-335 ◽

Cited By ~ 1

Author(s):

Changkang Pan ◽

Frances Liu ◽

Michael Motto

Keyword(s):

Structure Elucidation ◽

Drug Formulation ◽

Formulation Development ◽

Pharmaceutical Impurities

Download Full-text

Characterization of Impurities and Degradants in Protein Therapeutics by Mass Spectrometry

Characterization of Impurities and Degradants Using Mass Spectrometry ◽

10.1002/9780470921371.ch12 ◽

2011 ◽

pp. 391-426 ◽

Cited By ~ 3

Author(s):

Li Tao ◽

Michael Ackerman ◽

Wei Wu ◽

Peiran Liu ◽

Reb Russell

Keyword(s):

Mass Spectrometry ◽

Protein Therapeutics

Download Full-text

Investigation of Degradation Products and Extractables in Developing Topical OTC (Over the Counter) and NCE (New Chemical Entity) Consumer Healthcare Medication Products

Characterization of Impurities and Degradants Using Mass Spectrometry ◽

10.1002/9780470921371.ch11 ◽

2011 ◽

pp. 337-390

Author(s):

Fa Zhang

Keyword(s):

Degradation Products ◽

Chemical Entity ◽

Over The Counter ◽

Consumer Healthcare ◽

New Chemical Entity

Download Full-text

Identification and Quantification of Degradants and Impurities in Antibodies

Characterization of Impurities and Degradants Using Mass Spectrometry ◽

10.1002/9780470921371.ch13 ◽

2011 ◽

pp. 427-459

Author(s):

David M. Hambly ◽

Himanshu S. Gadgil

Keyword(s):

Identification And Quantification

Download Full-text

LC Method Development and Strategies

Characterization of Impurities and Degradants Using Mass Spectrometry ◽

10.1002/9780470921371.ch2 ◽

2011 ◽

pp. 59-79

Author(s):

Gang Xue ◽

Yining Zhao

Keyword(s):

Method Development

Download Full-text

Practical Application of Very High-Pressure Liquid Chromatography across the Pharmaceutical Development-Manufacturing Continuum

Characterization of Impurities and Degradants Using Mass Spectrometry ◽

10.1002/9780470921371.ch7 ◽

2011 ◽

pp. 213-229

Author(s):

Brent Kleintop ◽

Qinggang Wang

Keyword(s):

High Pressure ◽

Liquid Chromatography ◽

High Pressure Liquid Chromatography ◽

Practical Application ◽

Pharmaceutical Development ◽

Very High

Download Full-text

Characterization of Impurities and Degradants Using Mass SpectrometryLatest Publications

TOTAL DOCUMENTS

H-INDEX

Published By John Wiley & Sons, Inc.

Isotope Patten Recognition on Molecular Formula Determination for Structural Identification of Impurities

Frontmatter

Impurity Identification for Drug Substances

Orbitrap High-Resolution Applications

Structure Elucidation of Pharmaceutical Impurities and Degradants in Drug Formulation Development

Characterization of Impurities and Degradants in Protein Therapeutics by Mass Spectrometry

Investigation of Degradation Products and Extractables in Developing Topical OTC (Over the Counter) and NCE (New Chemical Entity) Consumer Healthcare Medication Products

Identification and Quantification of Degradants and Impurities in Antibodies

LC Method Development and Strategies

Practical Application of Very High-Pressure Liquid Chromatography across the Pharmaceutical Development-Manufacturing Continuum

Characterization of Impurities and Degradants Using Mass Spectrometry
Latest Publications